Deals
Boundless Bio Raises Fresh Capital to Boost extrachromosomal DNA Targeting Therapeutic Efforts
2021-04-30
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
Samsung Biologics Renews Manufacturing Deal to Expand Production of TG Therapeutics’ Cancer Drug
2021-04-27
Sanofi to Go After mRNA Based Cancer Treatments, Acquires Cambridge Startup for $470 Million
2021-04-12
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
Amgen Makes Second Acquisition Move Within a Month, Bolsters Inflammatory Disease Portfolio
2021-04-02
FTC Blocks Illumina’s $7 Billion Acquisition Bid to Restrict Monopoly of Cancer Diagnostic Market
2021-04-01
Merck Spinoff Expands Healthcare Business by Investing $240 Million in Acquiring Alydia Health
2021-03-31
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03